Antibodies against complement component C5 prevent antibody-mediated rejection after lung transplantation in murine orthotopic models with skin-graft-induced pre-sensitization
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1863-6713
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antibodies against complement component C5 prevent antibody-mediated rejection after lung transplantation in murine orthotopic models with skin-graft-induced pre-sensitization ; day:29 ; month:6 ; year:2022 ; pages:1-10
General thoracic and cardiovascular surgery ; (29.6.2022), 1-10
- Urheber
-
Shiina, Yuki
Suzuki, Hidemi
Hata, Atsushi
Kaiho, Taisuke
Matsumoto, Hiroki
Toyoda, Takahide
Sakairi, Yuichi
Wada, Hironobu
Motohashi, Shinichiro
Yoshino, Ichiro
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11748-022-01844-0
- URN
-
urn:nbn:de:101:1-2022082020383740545893
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.09.2025, 10:40 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shiina, Yuki
- Suzuki, Hidemi
- Hata, Atsushi
- Kaiho, Taisuke
- Matsumoto, Hiroki
- Toyoda, Takahide
- Sakairi, Yuichi
- Wada, Hironobu
- Motohashi, Shinichiro
- Yoshino, Ichiro
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats : Antibody-mediated rejection of arterialised venousallografts is inhibited by immunosuppression in rats
HLA antibody-mediated pathways in human endothelial cells and transplant rejection
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation
α1-Antitrypsin attenuates acute rejection of orthotopic murine lung allografts
Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
Validation of a molecular diagnostics for antibody-mediated rejection in human endomyocardial biopsies
Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis
Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection
C5
C.5.
Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats : Antibody-mediated rejection of arterialised venousallografts is inhibited by immunosuppression in rats
HLA antibody-mediated pathways in human endothelial cells and transplant rejection
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation
α1-Antitrypsin attenuates acute rejection of orthotopic murine lung allografts
Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
Validation of a molecular diagnostics for antibody-mediated rejection in human endomyocardial biopsies
Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis
Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection
C5
C.5.
Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats : Antibody-mediated rejection of arterialised venousallografts is inhibited by immunosuppression in rats
HLA antibody-mediated pathways in human endothelial cells and transplant rejection
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation
α1-Antitrypsin attenuates acute rejection of orthotopic murine lung allografts
Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
Validation of a molecular diagnostics for antibody-mediated rejection in human endomyocardial biopsies
Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis
Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection
C5